WT
CORT icon

Whittier Trust’s Corcept Therapeutics CORT Stock Holding History

Whittier Trust’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.8K Sell
402
-5,000
-93% -$302K ﹤0.01% 917
2026
Q1 		$221K Buy
5,402
+5,000
+1,244% +$187K ﹤0.01% 572
2025
Q4 		$14.4K Hold
402
– – ﹤0.01% 1080
2025
Q3 		$35.4K Hold
402
– – ﹤0.01% 915
2025
Q2 		$29.5K Hold
402
– – ﹤0.01% 1046
2025
Q1 		$45.9K Hold
402
– – ﹤0.01% 947
2024
Q4 		$20.3K Hold
402
– – ﹤0.01% 1106
2024
Q3 		$18.6K Hold
402
– – ﹤0.01% 1123
2024
Q2 		$13.1K Sell
402
-325
-45% -$8.9K ﹤0.01% 1200
2024
Q1 		$18.3K Buy
727
+325
+81% +$7.68K ﹤0.01% 1151
2023
Q4 		$13.1K Hold
402
– – ﹤0.01% 1187
2023
Q3 		$10.9K Hold
402
– – ﹤0.01% 1246
2023
Q2 		$8.94K Hold
402
– – ﹤0.01% 1285
2023
Q1 		$8.7K Hold
402
– – ﹤0.01% 1326
2022
Q4 		$8.16K Hold
402
– – ﹤0.01% 1331
2022
Q3 		$10K Hold
402
– – ﹤0.01% 1338
2022
Q2 		$10K Hold
402
– – ﹤0.01% 1316
2022
Q1 		$9K Hold
402
– – ﹤0.01% 1345
2021
Q4 		$8K Hold
402
– – ﹤0.01% 1339
2021
Q3 		$8K Hold
402
– – ﹤0.01% 1271
2021
Q2 		$9K Hold
402
– – ﹤0.01% 1278
2021
Q1 		$10K Hold
402
– – ﹤0.01% 1247
2020
Q4 		$11K Hold
402
– – ﹤0.01% 1138
2020
Q3 		$7K Hold
402
– – ﹤0.01% 1173
2020
Q2 		$7K Hold
402
– – ﹤0.01% 1107
2020
Q1 		$5K Hold
402
– – ﹤0.01% 1209
2019
Q4 		$5K Hold
402
– – ﹤0.01% 1230
2019
Q3 		$6K Buy
+402
New +$4.94K ﹤0.01% 1217

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Whittier Trust's CORT Position: Q2 2026 in Review

Whittier Trust reduced its Corcept Therapeutics (CORT) stake by 93% in Q2 2026, selling an estimated $302K and leaving 402 shares worth $36.8K. The position accounts for ﹤0.01% of the portfolio, ranked #917.

Whittier Trust first reported a position in CORT in Q3 2019 and has held it in 28 quarters since. The position peaked at $221K in Q1 2026. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Whittier Trust held 402 shares of Corcept Therapeutics worth $36.8K as of Q2 2026.
  • Whittier Trust sold 5,000 Corcept Therapeutics shares in Q2 2026, an estimated $302K.
  • Corcept Therapeutics made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #917 holding.
  • Whittier Trust first reported a position in Corcept Therapeutics in Q3 2019 and has held it in 28 quarters since.
  • Whittier Trust's Corcept Therapeutics position peaked at $221K in Q1 2026.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.